Clinical characteristics of Crohn's disease in 72 families
Registre des Maladies Inflammatoires du Tube Digestif du Nord-Ouest de la France (No. 92/R12), Unit of Epidemiology, Centre Hospitalier Régional et Universitaire, Lille, France. Gastroenterology
(Impact Factor: 16.72).
09/1996; 111(3):604-7. DOI: 10.1053/gast.1996.v111.pm8780563
Familial aggregation argues for genetic susceptibility to Crohn's disease. The aim of this study was to compare the age of onset and the clinical features of Crohn's disease between patients with familial disease and those with sporadic disease and investigate the concordance for disease location and type among relatives with Crohn's disease.
Seventy-two families with 2 (n = 55), 3 (n = 8), 4 (n = 6), and 5 or more (n = 3) affected first-degree relatives were selected for the study. A population of 1377 patients with sporadic nonfamilial Crohn's disease was used for comparison.
Clinical data were obtained from 176 patients with familial Crohn's disease (79 men and 97 women). Median age at onset was younger in familial Crohn's disease than in sporadic cases: 22 vs. 26.5 years (P < 0.01). In familial cases, fewer patients had exclusively colonic involvement and more patients had both small bowel and colonic involvement. Among relatives of families with 2 affected members, 56% were concordant for disease location and 49% for disease type. These percentages reached 83% and 76%, respectively, within families with more than 2 affected members.
Patients with familial Crohn's disease are characterized by an early age at onset with more extensive disease and may represent a homogeneous clinical subgroup with a particularly strong genetic influence.
Available from: Michael Genin
- "Geographic variation of IBD provides clues for researchers to investigate possible environmental etiologic factors. Northern France is characterized by a high incidence of CD with a continuous increase over 20 years, especially in adolescents and young adults (Chouraki et al. 2011; Colombel et al. 1996). Using a Bayesian hierarchical model, we recently reported spatial heterogeneity in the incidence of CD with a predominance of the disease in agricultural areas (Declercq et al. 2010). "
[Show abstract] [Hide abstract]
ABSTRACT: Geographical variations in Crohn’s Disease incidence have been reported worldwide suggesting putative variations in the distribution of environmental risk factors. A spatial heterogeneity in standardized incidence ratios of Crohn’s Disease was previously detected in northern France.
The goals of this study were to highlight significant atypical clusters in terms of incidence using scan statistics methodology and to study the evolution of these clusters during the study period.
Subjects and methods
From 1990 to 2006, the EPIMAD Registry recorded 6,472 Crohn’s Disease cases distributed in 273 administrative areas of northern France. Detection of clusters used space-time scan statistics adjusted for gender and age of patients.
Scan statistics provided identification of 18 significant clusters of two types: 14 time-constant clusters and 4 time-varying clusters. Among the fourteen time-constant clusters, 5 clusters of high incidence and 9 clusters of low incidence were detected. Among the four time-varying clusters, 3 clusters of high incidence and 1 cluster of low incidence were identified.
The existence of time-constant and time-varying clusters suggests that risk factors of Crohn’s Disease are still at work in our region.
Journal of Public Health 12/2013; 21(6):1-8. DOI:10.1007/s10389-013-0580-9 · 2.06 Impact Factor
- "The age-adjusted risk for IBD development in CD patients’ relatives was estimated in a study performed in Belgium, showing that the highest age-adjusted risk of IBD was found in offspring (10.4%) and that the age-adjusted empirical CD risk among first-degree relatives of patients with CD was higher in offspring (7.4%) than in parents, (1.9%) and slightly higher than in siblings (4.9%) . Moreover, in a French population-based study, first-degree relatives of CD patients appear to have an increased probability of sharing the same disease phenotype, especially according to disease location and behavior . Concordant results were found in a large Italian study in 128 families . "
[Show abstract] [Hide abstract]
ABSTRACT: The incidence and prevalence of inflammatory bowel disease (IBD) have distinctly changed over the past decades throughout Europe. From former North-South and West-East risk gradients, nowadays, classic high-risk areas for IBD in North and West present more stable incidences whereas in formerly low-risk zones the incidence is rising. These changes cannot be explained by genetic modifications in IBD patients' background, which draws attention to the possible existence of potent environmental factors triggering this epidemiologic shift. Important lessons can be drawn from different European population-based studies assessing the influence of environmental factors in familial IBD that may impact on the outcome of the disease and the management of the patients and their relatives.
Annals of Gastroenterology 03/2012; 25(3):188-192.
Available from: Amado Salvador Pena
- "Both CD and UC patients can be subdivided into a number of subgroups based on the course of the disease, clinical markers, and pathology. These differences are to a certain extent genetically determined (Bayless et al. 1996; Bouma et al. 1998, 1999; Colombel et al. 1996). "
[Show abstract] [Hide abstract]
ABSTRACT: There is evidence of a disbalance in the inflammatory regulation of patients with inflammatory bowel diseases (IBD). Interleukin-1 beta plays an important role in the pro-inflammatory response. Our aim was to study the influence which IL1B gene polymorphisms may have on the severity and course of these diseases. Ninety-six patients with ulcerative colitis (UC), 98 patients with Crohn's disease (CD), and 132 ethnically matched healty individuals (HC) were typed for the polymorphic sites in the promoter region (position -511) and in exon 5 (position +3953) of the IL1B gene, using polymerase chain reaction (PCR)-based methods. In the CD group a significant association (P = 0.009) was found in this pair of genes. Homozygotes for allele 1 at position +3953 were more often present (69% vs 31%) in the subgroup of patients carrying at least one copy of allele 2 at position -511. This association was significant in patients with non-perforating disease (P = 0.002), but was not present in patients with perforating-fistulizing disease. The distribution of both allelic pairs in the non-fistulizing group proved to be significantly different from HC (P < 0.05), UC (P < 0.03), and the fistulizing group (P < 0.05). There was a similar association in non-operated patients (P = 0.024), whereas no such association was found in surgically treated patients. Among carriers of allele 2 at position -511, UC patients with more severe bleeding symptoms (P = 0.006) were less frequently found. These results suggest that IL1B gene polymorphisms participate in determining the course and severity of inflammatory bowel disease and contribute to explain the heterogeneity of these diseases.
Immunogenetics 07/1999; 49(6):527-31. DOI:10.1007/s002510050530 · 2.23 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.